Dr. Cornblatt’s background in medicine and nutraceutical development has shaped his perspectives on modern medicine and the US’s approach to healthcare as a whole. While in medical school at Johns Hopkins, Dr. Cornblatt began identifying overlapping factors in cancer cases in his region that seemed to be overlooked, including physical environment, diet, and lifestyle. This sparked his commitment to asking the questions that healthcare professionals should ask their patients.
This has led him to his current role as the Chief Medical Officer for BioHarvest Sciences and co-founder and Chief Scientific Officer of International Nutrition Associates (INA). BioHarvest Sciences is the first and only fully validated industrial-scale plant cell technology platform for the production of plant metabolites.
He joins us to talk about the challenge of sourcing raw, organic ingredients, why the first question you get asked when you take your pet to the vet is "What do they eat?" but why human doctors don't ask that, and more about the science and ethics behind BioHarvest Sciences.
Biofarming Technology and the Future of Healthcare For Living Well
Featuring:
Dr. Brian Cornblatt
Dr. Brian Cornblatt is the Chief Medical Officer for BioHarvest Sciences and co-founder and Chief Scientific Officer of International Nutrition Associates (INA). INA provides clinical trial-backed nutraceuticals to countries throughout Asia and South America. Dr. Cornblatt’s most recent development has been a novel line of products, Avmacol, which deliver the essential ingredients needed to support the production of sulforaphane, a phytochemical with many emerging indications. Through his efforts, Avmacol has been used in eighteen supporting human clinical studies globally. Dr. Cornblatt is the inventor of three issued patents and four pending provisional patents focused on plant-based phytochemicals and bioactive and health promotion.
BIO: Dr. Brian Cornblatt is the Chief Medical Officer for BioHarvest Sciences and co-founder
and Chief Scientific Officer of International Nutrition Associates (INA). INA provides clinical trial-
backed nutraceuticals to countries throughout Asia and South America. Dr. Cornblatt’s most
recent development has been a novel line of products, Avmacol, which deliver the essential
ingredients needed to support the production of sulforaphane, a phytochemical with many
emerging indications. Through his efforts, Avmacol has been used in eighteen supporting
human clinical studies globally. Dr. Cornblatt is the inventor of three issued patents and four
pending provisional patents focused on plant-based phytochemicals and bioactive and health
promotion.